Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 625.00 | 384.25 | 761.00 | 773.00 | 0.9845 | 0.9692 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 625.00 | 384.25 | 855.00 | 773.00 | 1.1061 | 1.2103 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 400.00 | 773.00 | 0.5175 | 0.0406 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 625.00 | 384.25 | 317.00 | 773.00 | 0.4101 | -0.1737 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 763.00 | 773.00 | 0.9871 | 0.9743 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 586.00 | 773.00 | 0.7581 | 0.5197 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 537.00 | 773.00 | 0.6947 | 0.3936 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 702.00 | 773.00 | 0.9082 | 0.8178 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 625.00 | 384.25 | 951.00 | 773.00 | 1.2303 | 1.4563 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 694.00 | 773.00 | 0.8978 | 0.7972 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 790.00 | 773.00 | 1.0220 | 1.0436 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 625.00 | 384.25 | 559.00 | 773.00 | 0.7232 | 0.4502 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 1096.00 | 773.00 | 1.4179 | 1.8274 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 625.00 | 384.25 | 489.00 | 773.00 | 0.6326 | 0.2701 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 603.00 | 773.00 | 0.7801 | 0.5634 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 625.00 | 384.25 | 548.00 | 773.00 | 0.7089 | 0.4219 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 625.00 | 384.25 | 907.00 | 773.00 | 1.1734 | 1.3436 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 625.00 | 384.25 | 799.00 | 773.00 | 1.0336 | 1.0667 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 625.00 | 384.25 | 833.00 | 773.00 | 1.0776 | 1.1539 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 625.00 | 384.25 | 440.00 | 773.00 | 0.5692 | 0.1438 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 625.00 | 384.25 | 722.00 | 773.00 | 0.9340 | 0.8691 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 846.00 | 773.00 | 1.0944 | 1.1872 | |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 625.00 | 384.25 | 455.00 | 773.00 | 0.5886 | 0.1825 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 625.00 | 384.25 | 320.00 | 773.00 | 0.4140 | -0.1659 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 725.00 | 773.00 | 0.9379 | 0.8768 |